Government Employees Insurance Company, et al. v. Alexandr Zaitsev, M.D., et al.

Summary

The Eastern District of New York ruled on GEICO's motion for summary judgment in an alleged no-fault insurance fraud action involving medical practices and a diagnostic laboratory. The court granted limited declaratory relief concerning reimbursement for medically unnecessary and unauthorized urine drug testing, but denied summary judgment on unjust enrichment, New Jersey Insurance Fraud Prevention Act violations, and alleged unlawful self-referrals. The court held that material factual disputes remained regarding control of the medical practices and the defendants' knowledge.

Holdings

1. Summary judgment was denied because genuine disputes of material fact remained concerning whether Zaitsev retained control of Tri-State and Riverside and whether defendants engaged in unlawful self-referrals.
2. Ridgewood's testing for 6-MAM and MDEA was medically unnecessary, and GEICO was not required to reimburse those unnecessary medical expenses.
3. Ridgewood billed GEICO for unauthorized urine drug testing because the requisition forms were unsigned and therefore did not establish authorization by a qualified medical professional.
4. Summary judgment was denied on the unjust-enrichment claim because, although GEICO showed enrichment at its expense, whether equity and good conscience required restitution remained intertwined with unresolved claims and factual issues.
5. Summary judgment was denied because GEICO had not shown the absence of a genuine dispute regarding whether defendants knowingly submitted false or misleading information in support of reimbursement claims.
6. GEICO was entitled to a limited declaratory judgment that it was not obligated to pay Ridgewood's billing for unauthorized or medically unnecessary urine drug testing, but it was not entitled to a declaration concerning the alleged self-referral scheme or all remaining claims.

Questions Presented

1. Whether GEICO was entitled to summary judgment on its claim that defendants engaged in an unlawful self-referral scheme.
2. Whether GEICO was entitled to summary judgment concerning Ridgewood's billing for medically unnecessary 6-MAM and MDEA urine drug testing.
3. Whether GEICO was entitled to summary judgment concerning Ridgewood's billing for urine drug testing ordered on unsigned requisition forms.
4. Whether GEICO was entitled to summary judgment on its unjust-enrichment claim.
5. Whether GEICO was entitled to summary judgment on its New Jersey Insurance Fraud Prevention Act claim.
6. Whether GEICO was entitled to limited declaratory relief concerning payment for unauthorized or medically unnecessary urine drug testing.

Disposition

other